These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8535554)

  • 1. The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender.
    Hansson L; Zanchetti A
    Blood Press; 1995 Sep; 4(5):313-9. PubMed ID: 8535554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability.
    Hansson L; Zanchetti A
    Blood Press; 1997 Sep; 6(5):313-7. PubMed ID: 9360003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results.
    Hansson L; Zanchetti A
    Blood Press; 1994 Sep; 3(5):322-7. PubMed ID: 7866597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age].
    Kolloch RE; Rahn KH
    Dtsch Med Wochenschr; 1998 Jan; 123(1-2):1-5. PubMed ID: 9465848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study.
    Mancia G; Omboni S; Parati G; Clement DL; Haley WE; Rahman SN; Hoogma RP
    J Hypertens; 2001 Oct; 19(10):1755-63. PubMed ID: 11593094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
    Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A;
    J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hypertension Optimal Treatment Study (the HOT Study).
    Blood Press; 1993 Mar; 2(1):62-8. PubMed ID: 8193735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Hypertension Optimal Treatment Study: efficacy and tolerability on the 36th month].
    Herpin D; Mallion JM; Benkritly A; Baguet JP; Tremel F
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1043-8. PubMed ID: 9749162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment.
    Kjeldsen SE; Kolloch RE; Leonetti G; Mallion JM; Zanchetti A; Elmfeldt D; Warnold I; Hansson L
    J Hypertens; 2000 May; 18(5):629-42. PubMed ID: 10826567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term clinical tolerance of antihypertensive treatment during the HOT study. Groupe français de l'etude HOT].
    Mallion JM; Dahan R; Boutelant S; Benkritly A; Baguet JP; Noir-Clerc M
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1165-8. PubMed ID: 9404429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HOT study: quality of the blood pressure control after 2 years follow-up. Pour le Groupe français de l'étude HOT].
    Herpin D; Mallion JM; Dahan R; Benkritly A; Boutelant S; Baguet JP; Noir-Clerc M
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1175-9. PubMed ID: 9404431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
    Mallion JM; Baguet JP; Siché JP; Benkritly A
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
    Hansson L; Zanchetti A; Carruthers SG; Dahlöf B; Elmfeldt D; Julius S; Ménard J; Rahn KH; Wedel H; Westerling S
    Lancet; 1998 Jun; 351(9118):1755-62. PubMed ID: 9635947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension.
    Jönsson B; Hansson L; Stålhammar NO
    J Intern Med; 2003 Apr; 253(4):472-80. PubMed ID: 12653877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.